Marco Vignetti

19PUBLICATIONS
120CO-AUTHORS
NanomedicineMajor global burdens of diseaseHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Aug 17, 2026
Real-world outcomes of venetoclax plus hypomethylating agents in unfit acute myeloid leukaemia: Results of the GIMEMA AML2320 trial.

|May 27, 2026
Association Between Socioeconomic Inequalities and Health-Related Quality of Life in Patients With Relapsed/Refractory Multiple Myeloma.

|Mar 06, 2026
Genomic structural variations contribute to inform prognosis in patients with cytogenetically normal acute myeloid leukemia.

Niccolò Bartalucci, Francesco Mannelli, Danilo Tarantino

|Mar 14, 2025
Assessing the economic burden of Waldenström's Macroglobulinemia (WM), Marginal Zone Lymphoma (MZL), and Chronic Lymphocytic Leukemia (CLL).

Matteo Scortichini, Martina Paoletti, Angela Ragonese

|Mar 06, 2025
Safety run-in and part 1 of GIMEMA AML1718: venetoclax combined with FLAI as induction treatment in non-low-risk AML.

Giovanni Marconi, Alfonso Piciocchi, Ernesta Audisio

|Nov 06, 2024
Acute promyelocytic leukemia: long-term outcomes from the HARMONY project.

Maria Teresa Voso, Luca Guarnera, Söhren Lehmann

Pageof 4

Frequent Collaborators

9 joint publications

Alfonso Piciocchi

6 joint publications

Adriano Venditti

6 joint publications

Maria Teresa Voso

4 joint publications

Massimo Breccia